Diversification of haematopoietic stem cells to specific lineages
By Stuart H. Orkin. Nature reviews genetics, 2000
676 citations recorded by the source corpus.
Subfields: Cell Biology, Hematology, Physiology
View Paper: https://www.semanticscholar.org/paper/baf1cf3eb2172596fd55d73ccc6327ff2501b5eb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cell Biology
In Hematology
In Physiology
Citations in the corpus
- Exponential scaling of single-cell RNA-seq in the past decade (2017, background): “Cells have traditionally been classified by their morphology or by expression of certain proteins in functionally distinct settings (Mosmann et al., 1986; Orkin, 2000; Poulin et al., 2016).”
- Stem cell niche: structure and function. (2005, background): “Bone marrow serves as the pioneer system for studying stem cells; the concept and basic features of stem cells were defined from studying hematopoietic stem cells (HSCs) (Orkin 2000, Till & McCulloch 1961, Weissman et al. 2001).”
- High-dimensional switches and the modeling of cellular differentiation (2004, neutral): “…of heterozygous and homozygous mutants, heterokaryon studies, or knock-down mutations (Weintraub, 1993, McDevitt et al., 1997, reviewed by Orkin, 2000; Crittenden et al., 2002), by monoallelic expression of a gene such as Pax5 (Nutt et al., 1999), and by dosage effects of interacting…”
- Hematopoiesis: an evolving paradigm for stem cell biology. (2008, background): “The genes encoding the SET-domain containing histone methyltransferase MLL and runt-domain Runx1 proteins are essential for generation of HSCs within the AGM (and possibly at other sites) (Orkin, 2000).”
- Stepwise reprogramming of B cells into macrophages. (2004, neutral): “C/EBP (a maintained by a set of more than a dozen lineage- bZip family transcription factor) may also play a role in restricted transcription factors that are part of a “tran- B cell differentiation, since ablation of this factor, which scription factor network” (Orkin, 2000; Sieweke and is expresse”
- Disruption of differentiation in human cancer: AML shows the way (2003, background): “As described above, most patients with AML that have mutations in PU.1 or C/EBPα do not have chromosome translocations such as t(8;21), t(15;17) or Inv16.”
- A Developmental Switch in the Response of DRG Neurons to ETS Transcription Factor Signaling (2005, neutral): “specification [40].”